Faculty
-
August 13, 2014
On ABC News, Robert Klitzman Explores the Ethics of New Ebola Treatment
Although the World Health Organization has approved the new, experimental Ebola medication ZMapp, the limited supply of the drug raises questions about which patients should be prioritized for treatment.
ABC News said, "ZMapp...has notably not been supplied to the Africans who make up the majority of victims."
Bioethics director Robert Klitzman commented, "We want to make sure that we have clear criteria to make sure that it's done fairly."
Faculty
Why measuring individual engagement alone no longer captures how organizations actually perform.
Faculty
ERM part-time lecturer Corey Hirsch examines what PHP2Shell reveals about the fragility of modern digital infrastructure and how AI-driven vulnerability discovery is reshaping cybersecurity risk management.
Faculty
PlaNYC 2030 reshaped NYC’s approach to urban planning, environmental policy, & climate resilience.
All News
